These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 12829616)

  • 1. Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth.
    Goukassian DA; Kishore R; Krasinski K; Dolan C; Luedemann C; Yoon YS; Kearney M; Hanley A; Ma H; Asahara T; Isner JM; Losordo DW
    Circ Res; 2003 Jul; 93(2):162-9. PubMed ID: 12829616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1.
    Chen M; Capps C; Willerson JT; Zoldhelyi P
    Circulation; 2002 Nov; 106(21):2707-13. PubMed ID: 12438297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F.
    Kim MJ; Park KG; Lee KM; Kim HS; Kim SY; Kim CS; Lee SL; Chang YC; Park JY; Lee KU; Lee IK
    Hypertension; 2005 Apr; 45(4):552-6. PubMed ID: 15723965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-kappaB activation in vascular smooth muscle cells.
    Karki R; Ho OM; Kim DW
    Biochim Biophys Acta; 2013 Mar; 1830(3):2619-28. PubMed ID: 23274740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
    Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic Hsp60 orchestrates the survival and inflammatory responses of vascular smooth muscle cells in injured aortic vessels.
    Choi B; Choi M; Park C; Lee EK; Kang DH; Lee DJ; Yeom JY; Jung Y; Kim J; Lee S; Kang SW
    Cardiovasc Res; 2015 Jun; 106(3):498-508. PubMed ID: 25870185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury.
    Hayashi K; Takahata H; Kitagawa N; Kitange G; Kaminogo M; Shibata S
    Neurol Res; 2001 Oct; 23(7):731-8. PubMed ID: 11680513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.
    Qin ZX; Yu P; Qian DH; Song MB; Tan H; Yu Y; Li W; Wang H; Liu J; Wang Q; Sun XJ; Jiang H; Zhu JK; Lu W; Huang L
    Atherosclerosis; 2012 Feb; 220(2):343-50. PubMed ID: 22153150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells.
    Obara H; Takayanagi A; Hirahashi J; Tanaka K; Wakabayashi G; Matsumoto K; Shimazu M; Shimizu N; Kitajima M
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2198-204. PubMed ID: 11031204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
    Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
    Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phenanthrene Derivative, 5,7-Dimethoxy-1,4-Phenanthrenequinone, Inhibits Cell Adhesion Molecule Expression and Migration in Vascular Endothelial and Smooth Muscle Cells.
    Lo HM; Hwang TL; Wu WB
    Pharmacology; 2017; 99(5-6):291-302. PubMed ID: 28268217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-mediated E2F1 suppression in endothelial cells: differential requirement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signal transduction pathways.
    Kishore R; Luedemann C; Bord E; Goukassian D; Losordo DW
    Circ Res; 2003 Nov; 93(10):932-40. PubMed ID: 14576193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliotoxin inhibits neointimal hyperplasia after vascular injury in rats.
    Pozo M; Izquierdo MC; de Nicolás R; Egido J; Ortiz A; González-Cabrero J
    J Vasc Res; 2009; 46(4):278-89. PubMed ID: 19033690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Lee HY; Chung JW; Youn SW; Kim JY; Park KW; Koo BK; Oh BH; Park YB; Chaqour B; Walsh K; Kim HS
    Circ Res; 2007 Feb; 100(3):372-80. PubMed ID: 17234971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
    Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
    Yue TL; Vickery-Clark L; Louden CS; Gu JL; Ma XL; Narayanan PK; Li X; Chen J; Storer B; Willette R; Gossett KA; Ohlstein EH
    Circulation; 2000 Nov; 102(19 Suppl 3):III281-8. PubMed ID: 11082402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways.
    Hall JL; Wang X; Van Adamson ; Zhao Y; Gibbons GH
    Circ Res; 2001 Jun; 88(12):1247-53. PubMed ID: 11420300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
    Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
    Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.